Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt

Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt, based in Ashland, OH, is one of the SAMHSA-registered treatment programs operating in OH. The facility's programming is outpatient (Outpatient), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt

Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. What tends to produce post-admission financial surprise is not the facility being out of network — it is the verbal assurance that did not make it into writing. Ask for the written VOB before admission, save the email, and the rest of the financial conversation becomes a lot simpler.

Specialty programming

The facility's documented specialty programming includes: Adult women, Adult men. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Before admission to Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Council on Alcoholism and Drug Abuse Daniel Bryant Yth and Fam Adol Trt offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.